Listen

Description

诺华因3名自免病受试者死亡紧急暂停8项CAR-T临床,百时美施贵宝同步暂停相关试验。本期拆解事件背后的风险逻辑,揭秘自免CAR-T赛道的安全新命题。

参考文献:

  1. Marissa Russo, FierceBiotech, 2026-08-31. "UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies" — 链接

  2. Tristan Manalac, BioSpace, 2026-09-01. "Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events" — 链接

  3. 王聪, 生物世界/网易, 2026-09-02. "3名患者死亡,诺华暂停8项CAR-T自身免疫疾病临床试验" — 链接

  4. 一一, RNAScript/虎嗅, 2026-09-02. "3例死亡,诺华暂停8项CAR-T自免临床:自身免疫需要怎样的CAR-T?" — 链接


前往小宇宙评论区与主播互动